131 results
Page 2 of 7
8-K
EX-99.1
4abaz06nw
4 Aug 22
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
6:07am
DEFA14A
kk2ttr s5ezfd9n2
18 Apr 22
Additional proxy soliciting materials
7:36am
8-K
EX-99.1
4n1mb2a7 jl
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
8-K/A
q17xa n2wo2gvm4
7 Jan 22
CLINICAL PROGRAM UPDATE AURORA 2 / voclosporin Updated January 2022
4:10pm
8-K/A
EX-99.1
ksbdq8kr sl
7 Jan 22
CLINICAL PROGRAM UPDATE AURORA 2 / voclosporin Updated January 2022
4:10pm
8-K
kxr9i1gdaq8l3 32gvb2
9 Dec 21
Regulation FD Disclosure
6:31am
8-K
EX-99.1
erd9w0u4te8uz
9 Dec 21
Regulation FD Disclosure
6:31am
S-3ASR
EX-1.2
tmyyjeuf5lt8d
19 Nov 21
Automatic shelf registration
5:04pm
8-K
EX-99.1
sjba9v80 roit
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
8-K
EX-99.1
6vsemnm31wbyfrk0
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
EX-99.1
43058cpmnunnw3jc5ho1
25 Jun 21
Regulation FD Disclosure
4:12pm
DEF 14A
7g69wbcn
10 May 21
Definitive proxy
4:06pm
10-Q
tcvrxcidc75tfxzjy9c
6 May 21
Quarterly report
4:14pm
PRE 14A
pdwhkjho8ayugqle9ue
27 Apr 21
Preliminary proxy
4:32pm